Program Book - Confex

5:20 pm
Management of Pregnancy
Lisa R. Sammaritano, MD; Hospital for Special Surgery; New York,
NY
5:45 pm
Question and Answer
Doruk Erkan, MD; Hospital for Special Surgery; New York, NY
Munther A. Khamashta, MD; The Rayne Institute, Kings College
London School of Medicine; London, United Kingdom
Lisa R. Sammaritano, MD; Hospital for Special Surgery; New York,
NY
Upon completion of this session, participants should be able to:
• assess the risk of thrombosis in individuals that test positive
for antiphospholipid antibodies
• review the data on primary prevention in such individuals
• identify the options for the management of thrombotic
manifestations of antiphospholipid syndrome
• discuss the evidence and best data supporting treatment
decisions in antiphospholipid syndrome
• review the therapeutic options for the obstetric
manifestations of antiphospholipid syndrome
• discuss the evidence and best data supporting treatment
decisions in obstetric antiphospholipid syndrome
ACR CONCURRENT ABSTRACT SESSIONS
4:30 - 6:00 pm
W470b
Epidemiology and Health Services Research V: Drugs
Moderators: Jeffrey R. Curtis, MD, MPH, MSPH; University of
Alabama at Birmingham; Birmingham, AL
Tim Bongartz, MD, MS; Mayo Clinic College of Medicine;
Rochester, MN
4:30 pm
801. Initiation of Biologic DMARDs and the Risk of
Hospitalization for Infection in Patients with Autoimmune
Diseases
Carlos Grijalva 1 , Lang Chen 2 , Elizabeth S. Delzell 2 , John Baddley 2 ,
Timothy Beukelman 3 , Kevin L. Winthrop 4 , Marie Griffin 5 , Lisa
Herrinton6, Liyan Liu 6 , Parivash Nourjah 7 , Nivedita M. Patkar 3 ,
Daniel H. Solomon 8 , James Lewis 9 , Fenglong Xie 2 , Kenneth G.
Saag 2 and Jeffrey R. Curtis 2 , 1 Vanderbilt University, Nashville,
TN, 2 University of Alabama at Birmingham, Birmingham, AL,
3
Univ of Alabama-Birmingham, Birmingham, AL, 4 Oregon Health
Science Univ, Portland, OR, 5 Vanderbilt, 6 Oakland, CA, 7 Rockville,
MD, 8 Brigham & Women’s Hospital and Harvard Medical School,
Boston, MA, 9 University of Pennsylvania
4:45 pm
802. Short Periods of Glucocorticoid Use Are Associated with a
Prolonged Risk of Osteonecrosis
Steven C. Vlad 1 , Donald R. Miller 2 , Yuqing Zhang 1 and David T.
Felson 1 , 1 Boston University School of Medicine, Boston, MA,
2
Edith Nourse Rogers Memorial VA Hospital, Bedford, MA
Lii 3 , Lang Chen 4 , David Graham 5 , Marie Griffin6, Mary Kowal 3 ,
Bindee Kuriya 7 , James Lewis 8 , Liyan Liu 9 , Kenneth G. Saag 10 and
Jeffrey R. Curtis 10 , 1 Brigham & Womens Hospital, Boston, MA,
2
UMass Medical School, Worcester, MA, 3 Brigham and Women’s
Hospital, Boston, MA, 4 University of Alabama at Birmingham,
Birmingham, AL, 5 Food and Drug Administration, 6 Vanderbilt,
7
University of Toronto, Toronto, ON, 8 University of Pennsylvania,
9
Kaiser Permanente, 10 Univ of Alabama-Birmingham,
Birmingham, AL
5:15 pm
804. Use of Bisphosphonates for the Prevention of
Glucocorticoid-Induced Osteoporosis in Rheumatoid Arthritis
— a Population Based Study
Diane Lacaille 1 , Mushfiqur Rahman1 and John Esdaile 2 , 1 Arthritis
Research Centre; University of British Columbia, Vancouver, BC,
2
University of Calgary, Calgary, AB
5:30 pm
805. Switching From Oral Bisphosphonates to Intravenous
Zoledronic Acid Is Associated with A Reduction In the Incidence
Rates of Morphometric Vertebral Fractures Among Patients
with Postmenopausal Osteoporosis — A Real-World Time-
Series Study
Peter Sun 1 , Jean Lian 2 , Chris Recknor3 and Julie Recknor 3 , 1 Kailo
Research Group, Indianapolis, IN, 2 Novartis Pharmaceuticals
Corp., East Hanover, NJ, 3 United Osteoporosis Centers,
Gainesville, GA
5:45 pm
806. Safety of Zoster Vaccine in Individuals with Rheumatoid
Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and
Inflammatory Bowel Disease
Jie Zhang 1 , Fenglong Xie 1 , Elizabeth S. Delzell 1 , Lang Chen 1 ,
Kenneth G. Saag 1 , Kevin L. Winthrop 2 and Jeffrey R. Curtis 3 ,
1
University of Alabama at Birmingham, Birmingham, AL,
2
Oregon Health Science Univ, Portland, OR, 3 Univ of Alabama-
Birmingham, Birmingham, AL
W181b
Imaging of Rheumatic Disease I: Ultrasonography and
Dual-emission X-ray Absorptiometry
Moderators: Wolfgang A. Schmidt, MD; Medical Centre
Rheumatol Berlin Buch; Berlin, Germany
Ralf G. Thiele, MD; University of Rochester; Rochester, NY
4:30 pm
807. Can Ultrasound (PDUS) Easily Detect Erosions Evaluation
of Physiological and Abnormal Cortical Breaks of Small Joints in
Healthy Individuals (HI) and Rheumatoid Arthritis (RA) Patients
by PDUS Comparison with Micro Computed Tomography (µCT)
Scan
Stephanie Finzel 1 , Philippe Aegerter 2 , Georg Schett 1 , Maria-
Antonietta D’Agostino 2 and OMERACT Ultrasound Task Force 3 ,
1
University of Erlangen-Nuremberg, Erlangen, Germany,
2
Versailles-Saint Quentin en Yvelines University- APHP, Ambroise-
Paré Hospital, Boulogne-Billancourt, Paris, France, Paris, France,
3
Paris, France
SUNDAY
November 6, 2011
5:00 pm
803. Cardiovascular Risk Reduction Associated with TNF
Blockade: Results From a Large Multi-Site Observational Study
Daniel H. Solomon 1 , Leslie R. Harrold 2 , Jeremy Rassen 1 , Huichuan
4:45 pm
808. Imaging As An Outcome Measure in Early Inflammatory
Arthritis: Monitoring Disease Activity and Patients’ Response
to Therapy Using Ultrasonography
2011 Program Book 45